Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management
Abstract
Steatotic liver disease (SLD) is a spectrum of highly prevalent liver diseases encountered at many different healthcare levels. Awareness about metabolic dysfunction-associated SLD (MASLD), MetALD (MASLD and increased alcohol intake) and ALD (alcohol-related liver disease) is increasing beyond hepatology, as reflected by the various SLD guidelines issued by scientific societies from different disciplines, including endocrinology. The guidance presented here aims to improve cross-disciplinary knowledge and know-how by providing guidance to healthcare professionals from a global, holistic, multi-society and multi-stakeholder perspective. The patient trajectory was used as an overarching anchor point to ensure uniform guidance at all points along the SLD spectrum, with the ultimate goal of improving patient identification and optimising care. This consensus guidance covers patient identification and risk stratification, relevant cross-disciplinary primary and secondary care approaches, referral to and from tertiary care and strategies for disease management and monitoring. (c) 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
Related
- Postpartum Stroke: The Importance of Early Recognition and Multidisciplinary Management
- Pulmonary Epithelioid Trophoblastic Tumor Without Demonstrable Uterine Involvement: A Case Report and Literature Review Highlighting Diagnostic Challenges and Multidisciplinary Management
- Lumbar Discal Cyst Causing Lumbar Radiculopathy: A Case Series of Multidisciplinary Management
- A randomized controlled trial of a multidisciplinary collaborative fatigue management program for patients undergoing hematopoietic stem cell transplantation: study protocol
- A Multidisciplinary Neuro-Lupus Program for the Evaluation and Management of Patients With SLE and Cognitive Concerns
BibTeX
@article{brouwer2026steatotic,
title = {{Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management}},
author = {Willem Pieter Brouwer and Luisa Vonghia and Maja Thiele and Jörn Schattenberg and Foteini Anastasiou and Sonja Beckmann and Elisabetta Bugianesi and Laurent Castera and Cyrielle Caussy and Ahmed Cordie and Ruth de Bruyne and Núria Fabrellas and Gema Frühbeck and Zouhir Gadi and Amalia Gastaldelli and Anja Geerts and Laura Haigh and Kate Hallsworth and Adriaan Holleboom and Carolin Lackner and Jeffrey V Lazarus and Juan Mendive and Maurice Michel and Vicki Mooney and Vlad Ratziu and Michael Roden and Arun J Sanyal and Wendy C Spearman and Horia Stefanescu and Dina Tiniakos and Emmanuel Tsochatsis and José Willemse and Faiez Zannad and Shira Zelber-Sagi and Aleksander Krag and Sven Francque},
journal = {JHEP Reports Innovation in Hepatology},
year = {2026},
month = aug,
doi = {10.1016/j.jhepr.2026.101798},
url = {https://hal.univ-lorraine.fr/hal-05732559v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management
AU - Willem Pieter Brouwer
AU - Luisa Vonghia
AU - Maja Thiele
AU - Jörn Schattenberg
AU - Foteini Anastasiou
AU - Sonja Beckmann
AU - Elisabetta Bugianesi
AU - Laurent Castera
AU - Cyrielle Caussy
AU - Ahmed Cordie
AU - Ruth de Bruyne
AU - Núria Fabrellas
AU - Gema Frühbeck
AU - Zouhir Gadi
AU - Amalia Gastaldelli
AU - Anja Geerts
AU - Laura Haigh
AU - Kate Hallsworth
AU - Adriaan Holleboom
AU - Carolin Lackner
AU - Jeffrey V Lazarus
AU - Juan Mendive
AU - Maurice Michel
AU - Vicki Mooney
AU - Vlad Ratziu
AU - Michael Roden
AU - Arun J Sanyal
AU - Wendy C Spearman
AU - Horia Stefanescu
AU - Dina Tiniakos
AU - Emmanuel Tsochatsis
AU - José Willemse
AU - Faiez Zannad
AU - Shira Zelber-Sagi
AU - Aleksander Krag
AU - Sven Francque
PY - 2026
DA - 2026/08/31
JO - JHEP Reports Innovation in Hepatology
DO - 10.1016/j.jhepr.2026.101798
UR - https://hal.univ-lorraine.fr/hal-05732559v1
AB - Steatotic liver disease (SLD) is a spectrum of highly prevalent liver diseases encountered at many different healthcare levels. Awareness about metabolic dysfunction-associated SLD (MASLD), MetALD (MASLD and increased alcohol intake) and ALD (alcohol-related liver disease) is increasing beyond hepatology, as reflected by the various SLD guidelines issued by scientific societies from different disciplines, including endocrinology. The guidance presented here aims to improve cross-disciplinary knowledge and know-how by providing guidance to healthcare professionals from a global, holistic, multi-society and multi-stakeholder perspective. The patient trajectory was used as an overarching anchor point to ensure uniform guidance at all points along the SLD spectrum, with the ultimate goal of improving patient identification and optimising care. This consensus guidance covers patient identification and risk stratification, relevant cross-disciplinary primary and secondary care approaches, referral to and from tertiary care and strategies for disease management and monitoring. (c) 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
SN - 2589-5559
ER -